Table 1

Details of the 3 Randomized Clinical Trials (RCTs) (Primary and Follow-Up Studies) of Patients With Malignant Melanoma of the Extremities Who Underwent Wide or Narrower Excision

SeriesMethodsParticipantsInterventionsOutcomes
Veronesi et al, 1988 (12) (primary study)Multicentre international RCT
Blinding of:
 randomization: yes
 intervention: no
 outcome measuremes: no
Complete follow-up: no (1 lost)
612 adults with cutaneous melanoma up to 2 mm Breslow thickness307 patients treated with 3-cm margin v. 305 with 1-cm margin of excision.
Age, sex, Breslow thickness, ulceration, anatomic site similar
55 mo OS, DFS and LRR
Veronesi et al, 1991 (15) (follow-up study)Follow-up to Veronesi et al 1988 primary studySame as Veronesi et al 1988Same as Veronesi et al 19888 yr OS, DFS and LRR
Balch et al, 1993 (13) (primary study)Multicentre, international RCT
Blinding of:
 randomization: not stated
 intervention: no
 outcome measures: only for local recurrence
Complete follow-up: no (2.3% lost)
486 adults with cutaneous melanoma 1–4 mm Breslow thickness242 patients treated with 4-cm margin v. 244 with 2-cm margin of excision.
Age, sex, Breslow thickness, ulceration, anatomic site similar
5 yr OS, median 6 yr LRR
Wound complications
Need for skin graft
LOHS
Balch et al, 2001 (16) (follow-up study)Follow-up to Balch et al 1993 primary studySame as Balch 1993Same as Balch et al 199310 yr mean OS and LRR
Ringborg et al, 1996 (14) (primary study)Multicentre, international RCT
Blinding of:
 randomization: yes
 intervention: no
 outcome measurements: can’t tell for recurrence
Complete follow-up: yes
769 adults with cutaneous melanoma 0.8–2 mm Breslow thickness396 patients treated with 5-cm margin v. 373 with 2-cm margin of excision.
Age, sex, Breslow thickness, ulceration, anatomic site similar
5 yr OS, 5 yr melanoma survival, median 4 yr DFS, median 4 yr LRR
Cohn-Cedermark et al, 2000 (17) (follow-up study)Follow-up to Ringborg et al 1996 primary study with added patients989 adults with cutaneous melanoma513 patients treated with 5-cm margin v. 476 with 2-cm margin of excision11 yr OS and melanoma survival
8 yr DFS and LRR
  • LOHS = length of hospital stay, OS = overall survival, LRR = local recurrence rate, DFS = disease-free survival.